NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Clinical trial NCT06889766 · RECRUITING
Trial details
- NCT number
- NCT06889766
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-24
- Primary completion
- 2029-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.